Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

UDENYCA

PEGFILGRASTIM-CBQV

Standard Dose
6MG/0.6ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview UDENYCA is listed in Drugs@FDA under application 761039 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PEGFILGRASTIM-CBQV Form and strength INJECTABLE;INJECTION - 6MG/0.6ML Sponsor COHERUS BIOSCIENCES INC Submission history Latest submission status date: 2023-12-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview UDENYCA is listed in Drugs@FDA under application 761039 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEGFILGRASTIM-CBQV Form and strength INJECTABLE;INJECTION - 6MG/0.6ML Sponsor COHERUS BIOSCIENCES INC Submission history Latest submission status date: 2023-12-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.